BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7983595)

  • 1. Physicochemical characterization of the various solid forms of carbovir, an antiviral nucleoside.
    Nguyen NA; Ghosh S; Gatlin LA; Grant DJ
    J Pharm Sci; 1994 Aug; 83(8):1116-23. PubMed ID: 7983595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc.
    Zhu H; Padden BE; Munson EJ; Grant DJ
    J Pharm Sci; 1997 Apr; 86(4):418-29. PubMed ID: 9109042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 1. Nedocromil magnesium.
    Zhu H; Khankari RK; Padden BE; Munson EJ; Gleason WB; Grant DJ
    J Pharm Sci; 1996 Oct; 85(10):1026-34. PubMed ID: 8897266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 3. Nedocromil calcium.
    Zhu H; Halfen JA; Young VG; Padden BE; Munson EJ; Menon V; Grant DJ
    J Pharm Sci; 1997 Dec; 86(12):1439-47. PubMed ID: 9423160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state phase transitions of AG337, an antitumor agent.
    Rastogi S; Zamansky I; Roy S; Tyle P; Suryanarayanan R
    Pharm Dev Technol; 1999; 4(4):623-32. PubMed ID: 10578517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical characterization of naproxen sodium hydrate and anhydrate forms.
    Di Martino P; Barthélémy C; Palmieri GF; Martelli S
    Eur J Pharm Sci; 2001 Dec; 14(4):293-300. PubMed ID: 11684403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical characterization of nedocromil sodium hydrates.
    Khankari R; Chen L; Grant DJ
    J Pharm Sci; 1998 Sep; 87(9):1052-61. PubMed ID: 9724554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical characterization of picotamide monohydrate and anhydrous picotamide.
    Bettinetti G; Mura P; Sorrenti M; Faucci MT; Negri A
    J Pharm Sci; 1999 Nov; 88(11):1133-9. PubMed ID: 10564061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of moricizine hydrochloride polymorphs.
    Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.
    Kimura K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Apr; 88(4):385-91. PubMed ID: 10187747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
    Chauvet A; Masse J; Ribet JP; Bigg D; Autin JM; Maurel JL; Patoiseau JF; Jaud J
    J Pharm Sci; 1992 Aug; 81(8):836-41. PubMed ID: 1357154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-state characterization of two polymorphs of aspartame hemihydrate.
    Leung SS; Padden BE; Munson EJ; Grant DJ
    J Pharm Sci; 1998 Apr; 87(4):501-7. PubMed ID: 9548905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid state properties of an oral iron chelator, 1,2-dimethyl-3-hydroxy-4-pyridone, and its acetic acid solvate. I: Physicochemical characterization, intrinsic dissolution rate, and solution thermodynamics.
    Chan HK; Venkataram S; Grant DJ; Rahman YE
    J Pharm Sci; 1991 Jul; 80(7):677-85. PubMed ID: 1941568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical analyses of phase transition and dehydration processes of a new oral 1beta-methylcarbapenem antibiotic agent, CS-834.
    Kobayashi K; Fukuhara H; Kawamoto I; Hata T; Sekine A; Uekusa H; Ohashi Y
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1570-3. PubMed ID: 12499592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical characterization of the methanol solvate of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1989 Jan; 78(1):28-34. PubMed ID: 2709315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The solid-state characterization of fusidic acid.
    Gilchrist SE; Letchford K; Burt HM
    Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
    Tong HH; Shekunov BY; York P; Chow AH
    Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.